‚ÄčIntraperitoneal (IP) Chemotherapy for Gynecologic Cancer

Intraperitoneal (IP) chemotherapy is a regional chemotherapy procedure in which surgeons insert a port in your abdomen to deliver chemotherapy.

Because the chemotherapy is confined to your abdomen, side effects to healthy tissue are minimal.

IP Chemotherapy for Treating Gynecologic Cancer

IP chemotherapy may be an ideal treatment for gynecologic tumors if they are:

  • Confined to the abdomen
  • Too advanced to remove surgically

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC)

HIPEC circulates heated chemotherapy through your abdomen, raising the temperature to between 105 and 107.6 F (40.6 and 42 C).

Heating the chemotherapy can increase the penetration into the layers of the cells in the abdomen.

Where to Go for IP and HIPEC Treatments

Patients of the Magee-Womens Gynecologic Cancer Program have access to these treatments, which may be ideal for many gynecologic cancers, through the David C. Koch Regional Perfusion Cancer Therapy Center at UPMC Shadyside in Pittsburgh, Pa.

  • Magee-Womens Hospital of UPMC
  • 300 Halket St.
  • Pittsburgh, PA 15213-3180
  • Main Hospital/Operator:
  • To find a physician, or schedule an appointment:
    1-866-MyMagee (696-2433)
  •     ©  UPMC  |   Contact UPMC  |   Disclaimer  |   Privacy Notice  |  Supplemental content provided by Healthwise, Incorporated. To learn more, visit
         Click here for information on active privacy alerts. Privacy and Breach Alerts